Scholtz & Company, LLC Beam Therapeutics Inc. Transaction History

Scholtz & Company, LLC

  • $207 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$68.02 - $99.06 $195,557 - $284,797
-2,875 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$84.37 - $133.6 $5,905 - $9,352
-70 Reduced 2.38%
2,875 $250,000
Q2 2021

Aug 09, 2021
BUY
$64.12 - $128.71 $188,833 - $379,050
2,945 New
2,945 $379,000

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.78B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Scholtz & Company, LLC Portfolio

Follow Scholtz & Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scholtz & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scholtz & Company, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email